Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
- PMID: 19767753
- PMCID: PMC2846760
- DOI: 10.1038/ng.450
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Abstract
Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To identify common PrCa susceptibility alleles, we previously conducted a genome-wide association study in which 541,129 SNPs were genotyped in 1,854 PrCa cases with clinically detected disease and in 1,894 controls. We have now extended the study to evaluate promising associations in a second stage in which we genotyped 43,671 SNPs in 3,650 PrCa cases and 3,940 controls and in a third stage involving an additional 16,229 cases and 14,821 controls from 21 studies. In addition to replicating previous associations, we identified seven new prostate cancer susceptibility loci on chromosomes 2, 4, 8, 11 and 22 (with P = 1.6 x 10(-8) to P = 2.7 x 10(-33)).
Conflict of interest statement
None
Figures


References
-
- Eeles RA, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–321. - PubMed
-
- Amundadottir LT, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38:652–658. - PubMed
-
- Gudmundsson J, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet. 2007;39:631–637. - PubMed
-
- Gudmundsson J, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007;39:977–983. - PubMed
Publication types
MeSH terms
Grants and funding
- CA54281/CA/NCI NIH HHS/United States
- G0500966/MRC_/Medical Research Council/United Kingdom
- C5047/A7357/CRUK_/Cancer Research UK/United Kingdom
- 10588/CRUK_/Cancer Research UK/United Kingdom
- P50 CA097186/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- DH_/Department of Health/United Kingdom
- C5047/A10692/CRUK_/Cancer Research UK/United Kingdom
- C5047/A3354/CRUK_/Cancer Research UK/United Kingdom
- C16913/A6835/CRUK_/Cancer Research UK/United Kingdom
- M01 RR00064/RR/NCRR NIH HHS/United States
- R01 CA128813/CA/NCI NIH HHS/United States
- G0501019/MRC_/Medical Research Council/United Kingdom
- R01CA128813/CA/NCI NIH HHS/United States
- M01 RR000064/RR/NCRR NIH HHS/United States
- R01CA84979/CA/NCI NIH HHS/United States
- C522/A8649/CRUK_/Cancer Research UK/United Kingdom
- CA97186/CA/NCI NIH HHS/United States
- T32 GM007814/GM/NIGMS NIH HHS/United States
- R01 CA084979/CA/NCI NIH HHS/United States
- N01-PC-35141/PC/NCI NIH HHS/United States
- C16913/A6135/CRUK_/Cancer Research UK/United Kingdom
- CA56678/CA/NCI NIH HHS/United States
- U01 CA089600/CA/NCI NIH HHS/United States
- R01 CA056678/CA/NCI NIH HHS/United States
- CA63464/CA/NCI NIH HHS/United States
- R01 CA072818/CA/NCI NIH HHS/United States
- CA92579/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- N01 PC035141/PC/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- P50 CA105641/CA/NCI NIH HHS/United States
- R01 CA092579/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- P50 CA069568/CA/NCI NIH HHS/United States
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- R37 CA054281/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases